CNMD Insider Trading
CONMED Corp | Electromedical & Electrotherapeutic Apparatus
Comprehensive Trading Performance Summary
The investment history of corporate insiders at CONMED Corp provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Electromedical & Electrotherapeutic Apparatus sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2010-11-22 23:24 | 2010-11-15 | Jones Gregory Renard | Officer - Vice President-Corporate QA/RA | SELL | $22.97 | 300 | $6,892 | 1,100 | -21.4% |
| 2010-11-05 22:25 | 2010-11-04 | CORASANTI JOSEPH J | Officer - President & CEO | OPT+S | $22.37 | 67,502 | $1,510,006 | 58,669 | 0.0% |
| 2010-08-04 20:24 | 2010-08-02 | Jones Gregory Renard | Officer - Vice President-Corporate QA/RA | SELL | $19.56 | 300 | $5,868 | 1,343 | -18.3% |
| 2010-05-05 20:00 | 2010-05-03 | ABRAHAM WILLIAM | Officer - Senior Vice President | OPT+S | $22.03 | 6,092 | $134,178 | 14,808 | 0.0% |
| 2010-02-09 20:28 | 2010-02-08 | Johnson David Allen | Officer - VP - Global Operations | SELL | $22.10 | 468 | $10,343 | 0 | -100.0% |
| 2010-02-09 20:23 | 2009-12-09 | Johnson David Allen | Officer - VP - Global Operations | SELL | $21.20 | 500 | $10,600 | 0 | -100.0% |
| 2009-12-16 00:46 | 2009-12-14 | CORASANTI JOSEPH J | Officer - President & CEO | OPT+S | $21.30 | 37,501 | $798,771 | 43,363 | 0.0% |
| 2009-10-28 19:02 | 2009-10-26 | Cohen Heather L | Officer - VP CORP HR&DEPUTY GEN COUNSEL | SELL | $22.95 | 1,000 | $22,950 | 1,320 | -43.1% |
| 2009-10-27 20:51 | 2009-10-26 | Cohen Heather L | Officer - VP CORP HR&DEPUTY GEN COUNSEL | SELL | $22.50 | 1,000 | $22,500 | 1,320 | -43.1% |
| 2009-03-10 23:52 | 2009-03-09 | Johnson David Allen | Officer - VP - Global Operations | SELL | $11.71 | 1,028 | $12,038 | 0 | -100.0% |
| 2009-03-07 01:03 | 2009-03-06 | TRYNISKI MARK E | Director | BUY | $11.74 | 2,000 | $23,480 | 2,200 | +1,000.0% |
| 2009-03-04 22:58 | 2009-03-03 | Cohen Heather L | Officer - VP CORP HR&DEPUTY GEN COUNSEL | BUY | $12.51 | 800 | $10,008 | 800 | +100.0% |
| 2009-03-04 22:58 | 2009-03-03 | Cohen Heather L | Officer - VP CORP HR&DEPUTY GEN COUNSEL | SELL | $12.27 | 800 | $9,817 | 0 | -100.0% |
| 2009-03-03 18:23 | 2009-03-02 | SHALLISH ROBERT D JR | Officer - Vice President/Finance/CFO | BUY | $12.14 | 1,000 | $12,140 | 15,525 | +6.9% |
| 2009-01-05 23:18 | 2008-12-31 | JONAS DANIEL | Officer - VP Legal Affairs, Gen. Counsel | BUY | $22.74 | 78 | $1,774 | 2,571 | +3.1% |
| 2009-01-05 23:45 | 2008-12-31 | SHALLISH ROBERT D JR | Officer - Vice President/Finance/CFO | BUY | $22.74 | 86 | $1,956 | 14,525 | +0.6% |
| 2008-09-24 00:04 | 2008-08-28 | CORASANTI EUGENE R | Director | OPT+S | $32.00 | 61,096 | $1,955,103 | 125,281 | 0.0% |
| 2008-09-16 17:04 | 2008-09-15 | Cohen Heather L | Officer - VP CORP HR&DEPUTY GEN COUNSEL | OPT+S | $31.40 | 4,000 | $125,604 | 2,070 | 0.0% |
| 2008-09-05 17:05 | 2008-08-15 | CORASANTI EUGENE R | Officer - Chaiman of Board & Vice Chair | OPT+S | $32.00 | 2,400 | $76,800 | 125,281 | 0.0% |
| 2008-08-29 20:54 | 2008-08-28 | CORASANTI EUGENE R | Officer - Chairman of Board & Vice Chair | OPT+S | $31.55 | 63,496 | $2,003,248 | 125,281 | 0.0% |
| 2008-08-29 19:14 | 2008-08-28 | ABRAHAM WILLIAM | Officer - Senior Vice President | SELL | $32.00 | 14,025 | $448,800 | 50,324 | -21.8% |
| 2008-08-18 20:58 | 2008-08-14 | CORASANTI EUGENE R | Director, Officer - Chairman of Board, Vice Chair | OPT+S | $32.02 | 23,797 | $761,913 | 125,281 | 0.0% |
| 2008-08-13 23:40 | 2008-08-12 | CORASANTI JOSEPH J | Officer - President & CEO | SELL | $31.76 | 11 | $349 | 33,987 | 0.0% |
| 2008-08-13 23:39 | 2008-08-12 | CORASANTI JOSEPH J | Officer - President & CEO | OPT+S | $31.93 | 29,997 | $957,696 | 33,998 | 0.0% |
| 2008-08-07 19:34 | 2008-08-05 | Johnson David Allen | Officer - VP - Global Operations | OPT+S | $31.00 | 856 | $26,534 | 0 | 0.0% |
| 2008-08-07 20:28 | 2008-08-06 | ABRAHAM WILLIAM | Officer - Senior Vice President | OPT+S | $31.10 | 3,469 | $107,898 | 64,349 | 0.0% |
| 2008-08-05 18:25 | 2008-08-01 | POMILIO LUKE A | Officer - Vice President & Controller | OPT+S | $31.00 | 3,000 | $93,000 | 2,092 | 0.0% |
| 2008-08-06 00:06 | 2008-08-04 | ABRAHAM WILLIAM | Officer - Senior Vice President | OPT+S | $31.09 | 11,532 | $358,576 | 64,349 | 0.0% |
| 2008-08-01 20:18 | 2008-07-31 | POMILIO LUKE A | Officer - Vice President & Controller | OPT+S | $31.24 | 5,394 | $168,509 | 5,092 | 0.0% |
| 2008-07-31 16:30 | 2008-07-30 | JONAS DANIEL | Officer - VP LEGAL AFFAIRS, GEN. COUNSEL | OPT+S | $31.00 | 10,000 | $310,000 | 2,435 | 0.0% |
| 2008-07-30 23:19 | 2008-07-30 | Cohen Heather L | Officer - VP CORP HR&DEPUTY GEN COUNSEL | OPT+S | $31.03 | 4,000 | $124,120 | 2,070 | 0.0% |
| 2008-07-30 22:06 | 2008-07-29 | GOLDEN JO ANN | Director | OPT+S | $31.00 | 4,500 | $139,500 | 1,762 | 0.0% |
| 2008-07-25 23:03 | 2008-07-24 | Cohen Heather L | Officer - VP CORP HR&DEPUTY GEN COUNSEL | SELL | $29.44 | 500 | $14,720 | 2,070 | -19.5% |
| 2008-02-28 00:38 | 2008-02-26 | CORASANTI EUGENE R | Director | SELL | $27.76 | 64,481 | $1,790,225 | 121,457 | -34.7% |
| 2008-02-27 21:12 | 2008-02-25 | CORASANTI EUGENE R | Director | SELL | $27.54 | 10,419 | $286,893 | 185,938 | -5.3% |
| 2008-02-25 23:52 | 2008-02-21 | CORASANTI EUGENE R | Director | SELL | $27.63 | 25,100 | $693,556 | 196,357 | -11.3% |
| 2007-08-24 17:26 | 2007-08-22 | MATTHEWS WILLIAM | Director | OPT+S | $29.39 | 4,500 | $132,255 | 4,500 | 0.0% |
| 2007-06-19 21:10 | 2007-06-15 | ACEY THOMAS | Officer - SECRETARY & TREASURER | SELL | $30.94 | 100 | $3,094 | 3,375 | -2.9% |
| 2007-06-15 18:29 | 2007-06-13 | ACEY THOMAS | Officer - SECRETARY & TREASURER | OPT+S | $30.57 | 1,500 | $45,855 | 3,428 | 0.0% |
| 2007-06-07 22:18 | 2007-06-05 | WILLIAMS FRANK R | Officer - VICE PRESIDENT | OPT+S | $31.54 | 24,017 | $757,465 | 4,926 | 0.0% |
| 2007-06-04 22:10 | 2007-05-31 | POMILIO LUKE A | Officer - Vice President & Controller | OPT+S | $31.23 | 16,047 | $501,153 | 3,996 | 0.0% |
| 2007-06-01 20:12 | 2007-05-30 | JONAS DANIEL | Officer - VP/Legal Affairs/Gen. Counsel | OPT+S | $31.16 | 6,507 | $202,750 | 1,288 | 0.0% |
| 2007-06-01 22:09 | 2007-05-30 | WOODARD GERALD G | Officer - PRESIDENT LINVATEC | OPT+S | $31.05 | 37,080 | $1,151,371 | 0 | 0.0% |
| 2007-05-24 20:21 | 2007-05-23 | ABRAHAM WILLIAM | Officer - SENIOR VICE PRESIDENT | SELL | $31.20 | 1,269 | $39,593 | 56,571 | -2.2% |
| 2007-05-23 19:44 | 2007-05-22 | CORASANTI EUGENE R | Director, Officer - Chairman of Board & Vice Chair | SELL | $31.00 | 3,925 | $121,675 | 227,057 | -1.7% |
| 2007-05-23 22:34 | 2007-05-22 | ABRAHAM WILLIAM | Officer - SENIOR VICE PRESIDENT | OPT+S | $31.04 | 25,921 | $804,531 | 57,840 | 0.0% |
| 2007-05-23 21:45 | 2007-05-21 | SHALLISH ROBERT D JR | Officer - V.P. Finance, & CFO | OPT+S | $30.95 | 26,513 | $820,707 | 9,793 | 0.0% |
| 2007-05-18 23:00 | 2007-05-17 | GOLDEN JO ANN | Director | OPT+S | $30.03 | 4,500 | $135,151 | 1,562 | 0.0% |
| 2007-05-18 22:07 | 2007-05-17 | DANIELS BRUCE | Director | OPT+S | $29.93 | 4,500 | $134,706 | 0 | 0.0% |
| 2007-05-18 22:08 | 2007-05-17 | SCHWARTZ STUART J | Director | OPT+S | $29.81 | 4,500 | $134,154 | 1,275 | 0.0% |
How to Interpret $CNMD Trades
Not every insider transaction in CONMED Corp is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CNMD shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CNMD
Insider activity data for CONMED Corp is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CNMD, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.